Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Fujian Institute of Research on the Structure of Matter presents interferon modulators

March 15, 2019

Not just for cancer anymore, CAR T cells tested in lupus

March 13, 2019

Discovery of new TRPV4 agonist as regulators of chondrogenic differentiation

March 11, 2019

Neutralizing gut bacterial fragments reduces autoimmunity

March 6, 2019

Tackling tendonitis

March 5, 2019

RUNX1 mRNA-containing nanomicelles prevent intervertebral disk degeneration in mice

March 5, 2019

Lupus Therapeutics collaborates with Takeda on phase I trial of TAK-079 for SLE

March 4, 2019

Bristol-Myers Squibb presents lysophospholipid S1P1 receptor agonists

March 4, 2019

Azetidine optimization leads to clinical candidate JTE-952 for rheumatoid arthritis

March 1, 2019

Miransertib shows promising therapeutic efficacy in children with Proteus syndrome

Feb. 28, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...